Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T17:03:41.761Z.
Calculation as of: 2026-10-06T17:03:41.761Z.
Quote observation: 2026-10-06T17:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 75b78fb0f07f9e339fd4071160809690f580f97426e97a581df10cf86c1fdb4f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Park Dental Partners, Inc. Common Stock
Market Cap
$93.48M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| Park Dental Partners, Inc. Common Stock (PARK) | $93.48M | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $91.23M | N/A |
| Equillium, Inc. (EQ)vs › | $90.73M | N/A |
| electroCore, Inc. (ECOR)vs › | $90.16M | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $97.00M | N/A |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.60M | N/A |
| Korro Bio, Inc. (KRRO)vs › | $97.49M | N/A |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $89.46M | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.61M | N/A |
| Rallybio Corporation (RLYB)vs › | $89.36M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
